Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.38 |
| ▸ | LSS | P48449 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9762163 | 1.00 | CHRM2 (0.52) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL26493932 | 1.00 | CHRM2 (0.52) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL465326 | 1.00 | CHRM2 (0.52) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL8376760 | 1.00 | CHRM2 (0.52) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL26493911 | 1.00 | CHRM2 (0.52) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL26493928 | 0.97 | CHRM2 (0.50) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL26493909 | 0.97 | CHRM2 (0.50) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL465323 | 0.97 | CHRM2 (0.48) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL7299330 | 0.94 | CHRM2 (0.48) | CHRM2ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL26493908 | 0.94 | CHRM2 (0.48) | CHRM2ALDH1A1LMNATSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117049970-A | N-methyl dihexylamine and preparation method and application thereof | 武汉纺织大学 | 2023-11-14 | — | — | CN | claimed |
| EP-4727916-A1 | MIXED AMIDE ESTER CONTAINING LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2026-04-22 | — | — | EP | disclosed |
| US-20250188020-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | ACUITAS THERAPEUTICS INC (CA) | 2025-06-12 | — | — | US | disclosed |
| US-20250025427-A1 | MIXED AMIDE ESTER CONTAINING LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2025-01-23 | — | — | US | disclosed |
| WO-2024259356-A1 | MIXED AMIDE ESTER CONTAINING LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2024-12-19 | — | — | WO | disclosed |
| US-12129223-B2 | Lipids for use in lipid nanoparticle formulations | Acuitas Therapeutics, Inc. (CA) | 2024-10-29 | — | — | US | disclosed |
| EP-4448485-A2 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2024-10-23 | — | — | EP | disclosed |
| CN-117049970-A | N-methyl dihexylamine and preparation method and application thereof | 武汉纺织大学 | 2023-11-14 | — | — | CN | disclosed |
| US-20230295075-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2023-09-21 | — | — | US | disclosed |
| US-20230295075-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2023-09-21 | — | — | US | disclosed |
| EP-2227507-B1 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2011-08-31 | — | — | EP | disclosed |
| US-20110021686-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHERAMINES | BASF SE (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20110021687-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENEIMINES | BASF SE (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20110009566-A1 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| EP-2227507-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2010-09-15 | — | — | EP | disclosed |
| WO-2010028975-A2 | THERMALLY CONDUCTIVE POLYAMIDE HAVING INCREASED FLOW CAPABILITY | BASF SE (DE) | 2010-03-18 | — | — | WO | disclosed |
| WO-2009077492-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009050094-A1 | THERMOPLASTIC POLYESTER MOLDING COMPOUNDS COMPRISING HIGHLY BRANCHED POLYETHER AMINES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
| US-6004669-A | ELECTROSTATIC CHARGING MEMBER, UNIFORMLY DISPERSED IN A MODIFIED RESIN AS A BASE POLYMER BEING MODIFIED BY AN AMINE GROUP WHICH HAS AN ACID-BASE INTERACTION WITH THE OXIDATION-PROCESSED ELECTRICALLY-CONDUCTING AGENT, | FUJI XEROX CO., LTD. (JP) | 1999-12-21 | — | — | US | disclosed |
| US-5925893-A | POLYESTERURETHANE IONOMER | FUJI XEROX CO., LTD. (JP) | 1999-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295075-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | PHOSPHO1, SGMS1, NPC1 | CHRM2 1634/4885ALDH1A1 1138/4885LMNA 196/4885 |
| US-20250188020-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | PHOSPHO1, SGMS1, NPC1 | CHRM2 1634/4885ALDH1A1 1138/4885LMNA 196/4885 |
| US-20250025427-A1 | MIXED AMIDE ESTER CONTAINING LIPIDS FOR USE IN LIPID NANOPARTICLES | LIPA, LIPC, PHOSPHO1 | CHRM2 796/4885ALDH1A1 552/4885LMNA 128/4885 |
| US-12129223-B2 | Lipids for use in lipid nanoparticle formulations | PHOSPHO1, SGMS1, NPC1 | CHRM2 1634/4885ALDH1A1 1138/4885LMNA 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.